Statement on Disclosure

AASLD is an accredited provider of continuing medical education and adheres to the policies and standards set forth by the Accreditation Council for Continuing Medical Education (ACCME). As such, all faculty members (including Program Planners, Program Chairs, Moderators, Panelists, and Presenters) and abstract authors are expected to fully disclose all financial relationships with commercial interests during the past 12 months. A commercial interest is defined as "any entity developing, producing, marketing, re-selling or distributing healthcare goods or services consumed by or used on patients."

To ensure compliance, AASLD expects that all program content and related materials will promote improvements or quality in health care and not a specific proprietary business interest or commercial bias.

AASLD staff and program committees reserve the right to change an abstract if the use of a trade name may be mistaken for commercial propaganda and may replace proprietary names with generic names. Logos promoting a commercial interest will be removed from any and all slides before presentation.

  • COI Review, Management and Resolution
  • CME Content Validation
  • Off-Label / Investigational Use Policy
  • Disclosures
  • Glossary of Terms

AASLD, in collaboration with The Liver Meeting® Program Chairs and Planning Committees will review all faculty and abstract presenter disclosures prior to the meeting. Any potential conflicts of interest will be managed via the following:

  • Slide Review* one – two months prior to the meeting.
  • Slide Review* as noted above, with an onsite audit of the presentation at the meeting.

*Presenters must comply with requests to submit their slides one – two months prior to the meeting. Any slides not received may result in the removal of your presentation from the program. At the conclusion of the slide review, presenters may be asked to alter the content of their presentation to ensure balance and eliminate any perception(s) of commercial bias.

All faculty member disclosures will appear in the Final Program, in The Liver Meeting® app and as the first slide of each presentation that will be provided by AASLD.